Second assessment of NeuroAIDS in Africa

Journal of NeuroVirology

Volumn 14, Issue 2, 2008, Pages 89-101

  Robertson, Kevin ^a   Kopnisky, Kathy ^b   Hakim, James ^c   Merry, Concepta ^d   Nakasujja, Noeline ^e   Hall, Colin ^a   Traore, Moussa ^f   Sacktor, Ned ^g   Clifford, David ^h   Newton, Charles ^i,j   Van Rie, Annelies ^k   Holding, Penny ^l,m   Clements, Janice ^g   Zink, Christine ^g   Mielke, Jens ⁿ   Hosseinipour, Mina ^o,p   Lalloo, Umesh ^q   Amod, Farida ^r   Marra, Christina ^h   Evans, Scott ^s   Liner, Jeff ^a   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^f UNIVERSITY OF BAMAKO   (Mali)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h WASHINGTON UNIVERSITY   (United States)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^k IL   (United States)

^l KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^o UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^q UNIVERSITY OF KWAZULU NATAL   (South Africa)

^r UNIVERSITY OF KWAZULU NATAL   (South Africa)

^s HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

HIV; Neurological disease; Neuropsychological assessment; Resource limited settings

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; BETA INTERFERON; COTRIMOXAZOLE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LEVACECARNINE; MINOCYCLINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

AFRICA; AIDS RELATED COMPLEX; ANTIINFLAMMATORY ACTIVITY; ATTITUDE TO HEALTH; CD4 LYMPHOCYTE PERCENTAGE; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; COMORBIDITY; CULTURAL FACTOR; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG PENETRATION; FETOMATERNAL TRANSFUSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LACTIC ACIDOSIS; MENTAL PERFORMANCE; MOTOR DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NEUROSYPHILIS; NONHUMAN; ONSET AGE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIMIAN IMMUNODEFICIENCY VIRUS; SOCIOECONOMICS; TOXOPLASMOSIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; EDUCATION; INCIDENCE; NEUROSCIENCE; POVERTY;

AFRICA; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; INCIDENCE; NERVOUS SYSTEM DISEASES; NEUROSCIENCES; POVERTY;

EID: 42949166651     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280701829793     Document Type: Review

References (73)